다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
캐나다
CSE
Defence Therapeutics Inc (DTC)
Defence Therapeutics Inc (DTC) 뉴스

DTC

Defence Therapeutics (DTC)

Defence Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:CSE:DTC

1

일자	시간	출처	헤드라인	심볼	기업
2022/02/17	00:00	InvestorsHub NewsWire	DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER	CSE:DTC	Defence Therapeutics Inc
2022/01/26	22:49	InvestorsHub NewsWire	Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9	CSE:DTC	Defence Therapeutics Inc
2021/12/01	02:32	InvestorsHub NewsWire	DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT	CSE:DTC	Defence Therapeutics Inc
2021/11/23	22:24	InvestorsHub NewsWire	DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER	CSE:DTC	Defence Therapeutics Inc
2021/11/10	01:50	InvestorsHub NewsWire	DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS	CSE:DTC	Defence Therapeutics Inc
2021/11/03	21:11	InvestorsHub NewsWire	VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS	CSE:DTC	Defence Therapeutics Inc
2021/10/13	22:15	InvestorsHub NewsWire	DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER	CSE:DTC	Defence Therapeutics Inc
2021/10/06	22:32	InvestorsHub NewsWire	DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA	CSE:DTC	Defence Therapeutics Inc
2021/09/29	21:30	InvestorsHub NewsWire	DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER	CSE:DTC	Defence Therapeutics Inc
2021/09/20	23:01	InvestorsHub NewsWire	DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS	CSE:DTC	Defence Therapeutics Inc
2021/09/14	21:13	InvestorsHub NewsWire	DEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODEL	CSE:DTC	Defence Therapeutics Inc
2021/09/07	20:35	InvestorsHub NewsWire	DEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATED	CSE:DTC	Defence Therapeutics Inc
2021/09/01	23:39	InvestorsHub NewsWire	The vaccination specialist is about to become popular	CSE:DTC	Defence Therapeutics Inc

검색 관련기사 보기:CSE:DTC

1

유화증권우

Japan Medical Dynamic Ma... (PK)

BNP Paribas Issuance

Amundi MSCI World V UCIT...

Afore Capital Iii

Hydro Environmental

Direxion Daily MSFT

VALEF494 Ex:49,49

Vontobel Financial Produ...

Amundi Global Aggregate ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관